Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (56.145)

31

Cost-effectiveness analysis of durvalumab, tremelimumab, and etoposide-platinum in first-line treatment of extensive-stage small cell lung cancer

enthalten in: Medicine | 2024

von Meng, M. | Liu, X. | Liang, X. | +2

32

Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia

enthalten in: BMC infectious diseases | 2024

von Ordóñez, J. | Huertas, V.

33

Treatment for Covid-19 with SARS-CoV-2 neutralizing antibody BRII-196(Ambavirumab) plus BRII-198(Lomisivir) : a retrospective cohort study

enthalten in: BMC pharmacology & toxicology | 2024

von Yalan, Q. | Lingfang, H. | Xisong, L. | +3

34

Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors

enthalten in: Journal for immunotherapy of cancer | 2024

von Frentzas, S. | Austria Mislang, A. | Lemech, C. | +7

35

Switching from omalizumab to mepolizumab in severe asthmatics : A post hoc analysis of the RELight study

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2024

von Kallieri, M. | Papaioannou, A. | Zervas, E. | +31

36

Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy

enthalten in: Allergy | 2024

von Wipperman, M. | Gayvert, K. | Atanasio, A. | +15

37

Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Rimini, M. | Stefanini, B. | Tada, T. | +75

38

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

enthalten in: The New England journal of medicine | 2024

von Choueiri, T. | Tomczak, P. | Park, S. | +131

39

Adjuvant Immunotherapy for Kidney Cancer - A New Strategy with New Challenges

enthalten in: The New England journal of medicine | 2024

von Voss, M. | Motzer, R.

40

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy : the ARON-2 study

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94